DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide studied in experimental research examining sleep-related neurophysiology, circadian signaling, and neuroendocrine regulation. Laboratory models frequently investigate its interaction with stress-associated pathways, neurotransmitter systems, and slow-wave sleep architecture.
The peptide was originally isolated in the 1970s from cerebral venous blood of sleeping rabbits during electrophysiological studies of sleep states. Subsequent research identified similar peptide immunoreactivity in mammalian tissues, including human milk.
Experimental observations suggest that DSIP levels follow a circadian rhythm, with measurable fluctuations across the sleep–wake cycle.
DSIP-related peptide activity has been detected in several regions of the central nervous system, including:
thalamus
cerebral cortex
cerebellum
hypothalamus
brainstem
Although the peptide has been studied for decades, no dedicated precursor gene or specific receptor has been definitively identified, suggesting its activity may involve broader neuromodulatory mechanisms.
DSIP is also reported to cross the blood–brain barrier, enabling investigation of central nervous system signaling effects in experimental models.
Research suggests that DSIP acts through multi-system neuromodulatory interactions rather than a single receptor pathway.
Experimental models indicate that DSIP may influence NMDA-related glutamatergic signaling. Studies have reported reductions in NMDA-activated neuronal currents in several brain regions, including the cortex, hippocampus, thalamus, and hypothalamus. These observations are associated with changes in intracellular calcium signaling and neuronal excitability.
Laboratory studies have reported that DSIP can modulate GABA-related inhibitory neurotransmission, including increased GABA-activated currents in neuronal models such as hippocampal and cerebellar cells.
These observations suggest a role for DSIP in research examining inhibitory–excitatory balance within central nervous system circuits.
Some experimental studies have reported interactions between DSIP signaling and endogenous opioid systems, including changes in central endorphin activity. In certain models, opioid receptor antagonists have been observed to modify DSIP-related neurophysiological responses.
DSIP has also been examined in experimental models investigating neuroendocrine signaling pathways.
Reported interactions include modulation of hypothalamic and pituitary signaling systems associated with:
corticotropin-releasing factor (CRF)
adrenocorticotropic hormone (ACTH)
gonadotropin-releasing hormone (GnRH)
luteinizing hormone (LH)
thyroid-stimulating hormone (TSH)
growth hormone–related pathways
These pathways are frequently investigated in research exploring stress physiology and circadian neuroendocrine regulation.
Experimental observations suggest DSIP may influence multiple neurotransmitter systems, including:
dopaminergic signaling
adrenergic pathways
serotonergic signaling
histamine-related neural pathways
Changes in neuropeptides such as substance P and β-endorphin have also been reported in certain experimental models.
Several studies examining neuronal stress models have reported that DSIP may influence antioxidant enzyme activity, including:
glutathione peroxidase (GPx)
superoxide dismutase (SOD)
catalase
glutathione reductase
These mechanisms are often investigated in experimental models studying oxidative stress, mitochondrial function, and neuronal metabolic regulation.
Experimental research suggests DSIP may utilize carrier-mediated transport mechanisms across the blood–brain barrier, including potential involvement of the choroid plexus transport system.
Such mechanisms are frequently studied in research examining neuropeptide transport and central nervous system peptide signaling.
Synonyms: Delta Sleep-Inducing Peptide, DSIP
Sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
Molecular Weight: ~848.8–849 Da
Molecular Formula: C35H48N10O15
CAS: 62568-57-4
Total Active Ingredient: 5 mg per vial - ( Vial format: lyophilized powder for enhanced stability.)
DSIP is commonly referenced in experimental research investigating:
sleep architecture and slow-wave sleep signaling
circadian rhythm regulation
neuroendocrine signaling pathways
excitatory–inhibitory neurotransmitter balance
stress-associated neurophysiology
oxidative stress and mitochondrial function
For a detailed neurobiological discussion of sleep architecture, CSTC circuit dynamics, and experimental OCD-related pathways, see our in-depth research overview.
→ OCD Circuit-Level Neurobiology Research
DSIP is frequently discussed in research exploring sleep, recovery, and cognitive function. Learn more about related compounds in our article: Best Neurotrophic Peptides for Cognitive Research and Brain Support.
In vitro research or further manufacturing use only. Not for human or animal use.
All information provided by PRG is for educational and informational purposes only.
Best Practices for Storing Peptides
To maintain the reliability of laboratory results, correct peptide storage is essential. Proper storage conditions help preserve peptide stability for years while protecting against contamination, oxidation, and breakdown. Although certain peptides are more sensitive than others, following these best practices will greatly extend their shelf life and structural integrity.
Preventing Oxidation & Moisture Damage
Peptides can be compromised by exposure to moisture and air—especially immediately after removal from a freezer.
Storing Peptides in Solution
Peptides in solution have a much shorter lifespan compared to lyophilized form and are prone to bacterial degradation.
Containers for Peptide Storage
Select containers that are clean, intact, chemically resistant, and appropriately sized for the sample.
Regenesis Peptide Storage Quick Tips
